rxstatShortages › Ipratropium Bromide

Ipratropium Bromide (Ipravent, Atrovent) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Ipratropium Bromide products are in shortage in Canada (2 of 16 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.

An inhaled bronchodilator used to open the airways in COPD and asthma.

Products affected
2 / 16
In shortage since
Mar 10, 2017
Reports on file
56
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
APO-IPRAVENT STERULES
0.025% · SOLUTION · APOTEX INC
DIN 02231494 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-IPRAVENT STERULES
125MCG · SOLUTION · APOTEX INC
DIN 02243827 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Resolved
IPRAVENT
42MCG · SOLUTION · AA PHARMA INC
DIN 02246084 · ended Jun 30, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-IPRATROPIUM STERINEBS
250MCG · SOLUTION · TEVA CANADA LIMITED
DIN 02216221 · ended Jun 16, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-IPRATROPIUM STERINEBS
250MCG · SOLUTION · TEVA CANADA LIMITED
DIN 02216221 · ended Apr 3, 2026 · Disruption of the manufacture of the drug.
Resolved
PMS-IPRATROPIUM
125MCG · SOLUTION · PHARMASCIENCE INC
DIN 02231135 · ended Aug 15, 2025 · Disruption of the manufacture of the drug.
Resolved
PMS-IPRATROPIUM
250MCG · SOLUTION · PHARMASCIENCE INC
DIN 02231245 · ended Nov 28, 2025 · Disruption of the manufacture of the drug.
Resolved
PMS-IPRATROPIUM
250MCG · SOLUTION · PHARMASCIENCE INC
DIN 02231244 · ended Aug 15, 2025 · Disruption of the manufacture of the drug.
Resolved
PMS-IPRATROPIUM
250MCG · SOLUTION · PHARMASCIENCE INC
DIN 02231244 · ended Jan 23, 2026 · Disruption of the manufacture of the drug.
Resolved
PMS-IPRATROPIUM
125MCG · SOLUTION · PHARMASCIENCE INC
DIN 02231135 · ended Sep 15, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP IPRATROPIUM HFA
20MCG · METERED-DOSE AEROSOL · JAMP PHARMA CORPORATION
DIN 02542587 · ended Jun 16, 2025 · Disruption of the manufacture of the drug.
Resolved
PMS-IPRATROPIUM
250MCG · SOLUTION · PHARMASCIENCE INC
DIN 02231244 · ended Jan 14, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 56 reports. All reports are on file with Health Canada.

What's happening

Ipratropium Bromide is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Ipratropium Bromide is classified under “DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE” (ATC R01AX).

Recent changes

Common questions

What is Ipratropium Bromide used for?

An inhaled bronchodilator used to open the airways in COPD and asthma.

When will Ipratropium Bromide be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Ipratropium Bromide in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (decongestants and other nasal prep.for topical use)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.